Saturation Genome Editing-Based Clinical Classification of BRCA2 Variants

Scientists utilized CRISPR–Cas9-based saturation genome editing in a humanized mouse embryonic stem cell line to determine the functional effect of variants of uncertain significance. They categorized nearly all possible single nucleotide variants in the region that encodes the carboxylate-terminal DNA-binding domain of BRCA2.